MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bio-Path Holdings Company Profile (NASDAQ:BPTH)

Consensus Ratings for Bio-Path Holdings (NASDAQ:BPTH) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (316.67% upside)

Analysts' Ratings History for Bio-Path Holdings (NASDAQ:BPTH)
Show:
DateFirmActionRatingPrice TargetActions
4/29/2015Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Maxim GroupSet Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Maxim GroupSet Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Maxim GroupInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Maxim GroupInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)